News for Priveterra Acquisition Corp. (PMGM)

Priveterra Acquisition Corp. II today announced that on April 29, 2024, the Company received a notice from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC...

Priveterra Acquisition Corp. II reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net income was USD 4.94 million...

Common stock and warrants of combined company will be listed on the New York Stock Exchange American under the symbols AEON and AEON WS, respectively ...

Priveterra Acquisition Corp. , a special purpose acquisition company led by Chairman & CEO, Robert Palmisano, along with President, Vikram Malik, and COO and CFO, Oleg Grodnensky, today announced...

U.S. stocks traded higher this morning, with the Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow trade...

U.S. stocks traded higher this morning, with the Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.14% to 35,275.55 while the NASDAQ rose 0.52% to 14,135.92. The S&P 500, also rose, gaining, 0.32% to 4,549.47.

GuruFocus Article or News written by GuruFocus Editor and the topic is about:

Priveterra Acquisition (PMGM) said Monday that the new AEON common stock and warrants have been approved to be listed on NYSE American LLC once it has merged with AEON Biopharma.Trading...

Following the completion of the business combination of Priveterra Acquisition (PMGM) with AEON Biopharma, AEON will be a wholly owned subsidiary of Priveterra, and Priveterra will...

Priveterra Acquisition, a special purpose acquisition company, currently trades on the Nasdaq.

Financing represents minimum cash required to consummate the business combination and bridge AEON through key episodic migraine data readout...